Health care providers and businesses turn to attorney Lisa Gora for advice on regulatory compliance and representation in corporate transactions. Lisa is also a leader in Epstein Becker Green’s cannabis practice, providing legal guidance to cannabis-related businesses in the evolving legal framework.
Lisa regularly analyzes federal and state statutes and regulations in connection with the federal Anti-Kickback Statute and Stark Law, New Jersey’s Codey Law and other state-specific self-referral laws, the federal False Claims Act, the New Jersey False Claims Act, Board of Medical Examiners regulations, HIPAA, HITECH, licensing and reimbursement issues, and other fraud and abuse laws. Her clients include health care professionals as well as group practices and other health care entities, such as hospitals, academic medical centers, ambulatory surgery centers, management service organizations, ambulatory care facilities, substance use treatment facilities, mental health facilities (outpatient and inpatient), and nursing homes, among others.
Lisa’s health care, corporate, and cannabis clients also rely on Lisa to guide them through transactional matters concerning mergers and acquisitions as well as the formation and structure of such entities, including joint ventures, affiliation agreements, and management service organizations. In addition, she reviews and prepares physician employment agreements and corporate-related ownership documents for medical practices and her cannabis clients.
On the forefront of the burgeoning cannabis industry and with many years of industry experience, Lisa helps clients in the cannabis space navigate the industry’s complicated and ever-changing regulatory landscape. Her cannabis law practice includes the representation of alternative treatment centers within the medicinal cannabis industry as well as start-ups and multistate operators in the personal adult-use cannabis industry, such as cultivators, manufacturers, retailers, delivery services, distributors, and testing laboratories. Lisa advises clients in connection with licensing, ownership, and regulatory compliance pursuant to state laws, rules, and regulations. Lisa also advises clients on regulatory considerations associated with anticipated mergers and acquisitions. Additionally, she provides advice to physicians, hospitals, and others doing business in the legal cannabis market in New Jersey concerning issues related to recommending, authorizing, administering, and possessing medical cannabis.
Further, Lisa frequently lectures on ownership in medical practices and cannabis entities (buying in and separating from) and the related considerations and challenges. She has lectured to residents and fellows of differing residency programs at medical universities within New Jersey and New York regarding the key components of physician-employment agreements and how to equitably negotiate such terms. Some of the medical centers she has presented at are Columbia University Medical Center (NY), Mount Sinai Hospital (NY), Bronx VA Medical Center (NY), and Monmouth Medical Center (NJ).
Lisa serves as Chair of the Medical Staff, Credentialing, and Peer Review Practice Group of the American Health Law Association. She is also Chair of the New Jersey State Bar Association Health Law Section and Co-Chair of the Cannabis Law Committee.
Lisa serves as co-author of the New Jersey Law Journal monthly column on the impacts of legal cannabis on New Jersey businesses. She was Editor-in-Chief of the first edition of Health Care and the Business of Cannabis: Legal Questions and Answers, a first-of-its-kind project published by the American Health Law Association, which offers insight on the interplay between medicinal cannabis and the health care industry, as well as related information on legal and practical considerations in connection with business opportunities surrounding medicinal cannabis and its by-products. She also co-authored “Medical Marijuana: State and Federal Law Thickets and Practical Implications” in the Health Law Handbook, published by Thomson Reuters in May 2020. Before joining Epstein Becker Green, Lisa was Co-Chair of the Cannabis Law team and a shareholder in the Corporate and Health Law teams at a regional law firm.